Bad Homburg vor der Höhe

RenalSense Announces Distribution Agreement in Israel with Medtechnica

Retrieved on: 
Monday, January 25, 2021
Companies, Religion and geography, Geography of Asia, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Masimo, Philips, Jérusalem

JERUSALEM, Jan. 25, 2021 /PRNewswire/ --RenalSense, a leading company in real-time renal diagnostics, today announced a distribution agreement with Medtechnica, Israel's largest distributor of medical equipment and health services.Medtechnica will market RenalSense's Clarity RMScritical care monitoring system to hospitals throughout Israel.

Key Points: 
  • JERUSALEM, Jan. 25, 2021 /PRNewswire/ --RenalSense, a leading company in real-time renal diagnostics, today announced a distribution agreement with Medtechnica, Israel's largest distributor of medical equipment and health services.Medtechnica will market RenalSense's Clarity RMScritical care monitoring system to hospitals throughout Israel.
  • RenalSense is currently in discussions with additional partners regarding distribution agreements for other key markets.
  • Medtechnica, founded in 1953, is the largest distributor of medical equipment and health services in Israel.
  • Manufacturers represented by Medtechnica include Fresenius Kabi, Philips, Boston Scientific, Getinge, Masimo, Hologic, Elekta, J&J, Hill-Rom among other blue chip companies.

CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care

Retrieved on: 
Tuesday, January 19, 2021
Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Cytosorbents Corporation, Health care, Cytokine storm, Germany, Health

CytoSorbents (NASDAQ:CTSO) Announces Korean Approval of CytoSorb, a Treatment of Deadly Cytokine Storm and Inflammation

Key Points: 
  • CytoSorbents (NASDAQ:CTSO) Announces Korean Approval of CytoSorb, a Treatment of Deadly Cytokine Storm and Inflammation
    Ms. Clare Kim, Managing Director of Fresenius Medical Care Korea commented, "In Korea, the sepsis mortality rate and incidence have increased steadily and remains a major problem in critical care.
  • Under these circumstances, we are pleased to introduce the cytokine adsorber, CytoSorb, to healthcare professionals and patients in Korea.
  • Fresenius Medical Care Korea remains committed to having a positive impact on the care of severely ill patients with CytoSorb."
  • Mr.Vincent Capponi, President and Chief Operating Officer of CytoSorbents, stated, "We are pleased to have successfully achieved approval of CytoSorb inKorea, in cooperation with our partner Fresenius Medical Care.

Fresenius Medical Care's Frenova enrolls patients in initiative to build world's largest genomic registry targeting kidney disease

Retrieved on: 
Monday, January 11, 2021
Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Germany, Health care, Kidney diseases, Nephrology, Calcium acetate/magnesium carbonate

The renal-focused genomic registry represents a new business line within Frenova, which is based in Fresenius Medical Care's Global Medical Office.

Key Points: 
  • The renal-focused genomic registry represents a new business line within Frenova, which is based in Fresenius Medical Care's Global Medical Office.
  • Frenova's new genomic registry will contain genetic sequencing data from chronic kidney disease patients worldwide, which will be used by researchers to improve the understanding of kidney disease.
  • Frenova developed the registry after researchers identified the lack of a large-scale, renal-focused registry of genomic and clinical data as a major impediment to kidney disease research.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius Kabi Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter

Retrieved on: 
Friday, January 8, 2021
FDA, Pharmaceutical, Health, Medical devices, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Germany, Companies, Bidiphar

Distributors should notify their customers and direct them to quarantine and discontinue distributing or dispensing the affected lot, and to return the product to Fresenius Kabi.

Key Points: 
  • Distributors should notify their customers and direct them to quarantine and discontinue distributing or dispensing the affected lot, and to return the product to Fresenius Kabi.
  • The recall letter and response form are available at https://www.fresenius-kabi.com/us/pharmaceutical-product-updates .
  • Customers with questions regarding this recall may contact Fresenius Kabi at 1-866-716-2459 Monday through Friday, during the hours of 8:00 a.m. to 5:00 p.m. Central Time.
  • Fresenius Kabi ( www.fresenius-kabi.com/us ) is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.

Fresenius Kabi and Kit Check Collaborate on RFID Compatibility

Retrieved on: 
Wednesday, December 9, 2020
Medical Supplies, Health, Hospitals, Practice Management, General Health, Pharmaceutical, Automatic identification and data capture, Drugs, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Radio-frequency identification, Propofol, Chemistry, Articles, Fresenius Kabi, Kit Check

Fresenius Kabi and Kit Check today announced the companies have entered into an agreement under which Fresenius Kabi +RFID medications will be read by the Kit Check inventory management solution.

Key Points: 
  • Fresenius Kabi and Kit Check today announced the companies have entered into an agreement under which Fresenius Kabi +RFID medications will be read by the Kit Check inventory management solution.
  • We are delighted to be partnering with Fresenius Kabi as part of our ongoing mission to increase interoperability across the pharmaceutical supply chain, said Kevin MacDonald, CEO and co-founder of Kit Check.
  • As part of Fresenius Kabis collaboration with Kit Check, +RFID medications, beginning with the anesthetic Diprivan (propofol), will be able to be read in the Kit Check system, allowing customers to access all of the relevant information for reliable product tracking.
  • In 2021, Fresenius Kabi expects to add more than 20 medicines to its +RFID portfolio in the United States.

Fresenius Kabi Issues Voluntary Nationwide Recall of a Single Lot of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

Retrieved on: 
Thursday, November 19, 2020
FDA, Pharmaceutical, Health, Surgery, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Germany, Companies, Industries, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Germany, Companies, Industries

Distributors should notify their customers and direct them to quarantine and discontinue distributing or dispensing any affected lots, and to return the product to Fresenius Kabi.

Key Points: 
  • Distributors should notify their customers and direct them to quarantine and discontinue distributing or dispensing any affected lots, and to return the product to Fresenius Kabi.
  • The recall letter and response form are available at https://www.fresenius-kabi.com/us/pharmaceutical-product-updates .
  • Customers with questions regarding this recall may contact Fresenius Kabi at 1-866-716-2459 Monday through Friday, during the hours of 8:00 a.m. to 5:00 p.m. Central Time.
  • Or, contact Fresenius Kabi at 1-800-551-7176, Monday through Friday, during the hours of 8:00 a.m. to 5:00 p.m. Central Time or via email at:

Vizient Announces Novaplus Enhanced Supply Agreement with Fresenius Kabi for 7 Additional Essential Medications

Retrieved on: 
Thursday, November 19, 2020
Hospitals, Health, Pharmaceutical, Practice Management, Medical Supplies, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Pharmacy, Life sciences, Germany, Industries, Vizient, Inc., Vizient Novaplus and the Novaplus Enhanced Supply Program

Vizient, Inc. today announced an agreement with Fresenius Kabi to add an additional seven medications to its Novaplus Enhanced Supply program , part of Vizients private label pharmacy solution.

Key Points: 
  • Vizient, Inc. today announced an agreement with Fresenius Kabi to add an additional seven medications to its Novaplus Enhanced Supply program , part of Vizients private label pharmacy solution.
  • The agreement brings an additional 4.5 million units of product across the seven medications including four that greatly impact the pediatric patient population.
  • Novaplus Enhanced Supply program now includes a total of 31 molecules with over 53 million units of additional inventory.
  • Fresenius Kabi was the first manufacturer to participate in Novaplus Enhanced Supply when it signed an agreement for six essential medications late last year.

VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement

Retrieved on: 
Thursday, November 19, 2020
Hospitals, Pharmaceutical, Health, Cardiology, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Vifor Pharma, Companies, Industries, Germany

Under the agreement, Fresenius Kabi will have the exclusive right to distribute and sell Veltassa across China.

Key Points: 
  • Under the agreement, Fresenius Kabi will have the exclusive right to distribute and sell Veltassa across China.
  • Stefan Schulze, CEO of Vifor Pharma Group comments, We are delighted to expand VFMCRPs collaboration with Fresenius Kabi.
  • The excellent commercial infrastructure, the well established relationships in nephrology and our existing successful collaboration make Fresenius Kabi our partner of choice to provide Veltassa to patients.
  • Oskar Haszonits, President Region Asia Pacific of Fresenius Kabi said, This agreement is an important step in intensifying our collaboration and relationship with VFMCRP in nephrology.

ProvideGx® Partners with Fresenius Kabi to Help Stabilize Supply of Heparin, a Vital Medication

Retrieved on: 
Wednesday, November 18, 2020
General Health, Other Health, Hospitals, Health, Pharmaceutical, Medicine, Clinical medicine, Intravenous fluids, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Health care, Heparin, Intravenous therapy

(NASDAQ: PINC), through its ProvideGx program, has partnered with Fresenius Kabi to supply pre-filled, single-use IV bags of heparin sodium injection, USP to healthcare providers, helping to stabilize the long-term supply of a medication that is necessary when performing a number of hospital inpatient procedures.

Key Points: 
  • (NASDAQ: PINC), through its ProvideGx program, has partnered with Fresenius Kabi to supply pre-filled, single-use IV bags of heparin sodium injection, USP to healthcare providers, helping to stabilize the long-term supply of a medication that is necessary when performing a number of hospital inpatient procedures.
  • As COVID-19 cases increase across the country, the partnership between Premier and Fresenius Kabi will help avoid shortages for the benefit of the patients who need this life-saving drug.
  • To help mitigate this problem and assure adequate supply to meet a potential future surge in demand, Fresenius Kabi sources its raw materials from multiple regions.
  • Fresenius Kabi is a global healthcare company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.

Fresenius Kabi Announces Inductees to Blood Donation Hall of Fame

Retrieved on: 
Monday, November 16, 2020
Medical Supplies, Health, Hospitals, Surgery, Practice Management, General Health, Transfusion medicine, Hematology, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Branches of biology, Medicine, Clinical medicine, Blood donation, the need for blood and blood donation, Fresenius Kabi

View the full release here: https://www.businesswire.com/news/home/20201116005181/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201116005181/en/
    The newest inductees to the Fresenius Kabi Blood Donation Hall of Fame are recognized for their passion and commitment to blood donation whether through their own donations or by educating and encouraging others to donate.
  • For more than 20 years, Fresenius Kabi has worked shoulder-to-shoulder with blood centers, donors and volunteers to help ensure patients have access to blood.
  • A person may only be inducted into the Fresenius Kabi Blood Donation Hall of Fame once.
  • Nominations for the 2021 Fresenius Kabi Donation Hall of Fame are due by June 11, 2021.